Bill
Bill > HB818
TX HB818
Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.
summary
Introduced
11/12/2024
11/12/2024
In Committee
03/05/2025
03/05/2025
Crossed Over
Passed
Dead
Introduced Session
89th Legislature Regular Session
Bill Summary
AN ACT relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.
AI Summary
This bill modifies the Texas Controlled Substances Act by adding two additional medications, mifepristone and misoprostol, to Schedule IV alongside the existing controlled substance carisoprodol. Notably, the bill includes a specific provision that exempts pregnant women from prosecution for possessing mifepristone or misoprostol for their own personal use. These medications are commonly associated with medical abortion procedures. The bill clarifies that the new legal provisions will only apply to offenses committed on or after September 1, 2025, which is the date the act will take effect. This means that for any offenses occurring before that date, the previous legal standards will continue to apply. The bill appears to be addressing the legal classification and potential use of these specific pharmaceutical substances within the context of Texas state law.
Committee Categories
Health and Social Services
Sponsors (8)
Valoree Swanson (R)*,
Briscoe Cain (R),
Caroline Harris Davila (R),
Terri Leo-Wilson (R),
A.J. Louderback (R),
David Lowe (R),
Joanne Shofner (R),
Cody Vasut (R),
Last Action
Referred to Public Health (on 03/05/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB818 |
| BillText | https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00818I.htm |
Loading...